| Thu, 22 Oct 2020 15:24:33: | Could a language test diagnose Alzheimer’s? IBM is laying the groundwork
|
| Thu, 22 Oct 2020 12:22:30: | Roche to pay Atea $350M for ex-U.S. rights to COVID-19 antiviral
|
| Thu, 22 Oct 2020 11:37:52: | Fresh from early successes, RA Capital bags $461M for new fund
|
| Thu, 22 Oct 2020 07:59:26: | How a drug derived from antiparasitic might combat blood cancer
|
| Thu, 22 Oct 2020 07:19:29: | New CEO, major Roche biobucks pact: Now, Rheos nabs ex-Biogen R&D exec as CSO
|
| Thu, 22 Oct 2020 07:11:12: | Pandemic vaccine programs cannot tell us whether they will save lives: Doshi
|
| Thu, 22 Oct 2020 00:39:13: | Be Biopharma debuts with $52M to advance engineered B-cell therapies
|
| Wed, 21 Oct 2020 12:56:13: | CRISPR stock slides as CAR-T death overshadows signs of efficacy
|
| Wed, 21 Oct 2020 11:42:55: | AstraZeneca tipped to restart COVID-19 vaccine trial this week: report
|
| Wed, 21 Oct 2020 11:23:24: | Biogen finally culls MS dud opicinumab, adds SMA gene therapy to the garbage heap
|
| Wed, 21 Oct 2020 08:07:15: | GSK sees 'robust immune response' from RSV vaccine hopefuls
|
| Tue, 20 Oct 2020 23:04:52: | InCarda raises $30M to reimagine afib treatment with drug-device combo
|
| Tue, 20 Oct 2020 17:10:39: | Inhaled antibody drug for COVID-19 clears coronavirus in animals
|
| Tue, 20 Oct 2020 15:36:53: | SparingVision raises €44.5M to develop mutation-agnostic gene therapy
|
| Tue, 20 Oct 2020 13:38:19: | COVID-19 vaccine biotech Vaccitech nabs Pfizer, Kite vet as full-time CMO
|
| Tue, 20 Oct 2020 12:43:09: | Merck's rival to Pfizer's Prevnar 13 hits goal in phase 3 again
|
| Tue, 20 Oct 2020 11:57:56: | Covance to 'transform' into a decentralized CRO
|
| Tue, 20 Oct 2020 10:50:52: | U.K. set to infect volunteers with coronavirus in world's first COVID-19 challenge study
|
| Mon, 19 Oct 2020 14:30:47: | Intellia to kick-start first single-course 'curative' CRISPR shot, as it hopes to beat rivals Alnylam, Ionis and Pfizer
|
| Mon, 19 Oct 2020 12:41:39: | Breast cancer study uncovers new RNA targets for treatment and diagnostics
|
| Mon, 19 Oct 2020 12:28:41: | Kite's former EU chief Nowers joins NK cell startup ONK as CEO
|
| Mon, 19 Oct 2020 08:52:07: | Evotec nabs Gates Foundation cash for low-income country COVID-19 antibody work
|
| Fri, 16 Oct 2020 12:02:09: | Eli Lilly strikes deal to sell R&D campus to UCB
|
| Fri, 16 Oct 2020 07:48:50: | Galapagos' osteoarthritis drug flunks phase 2, dashing hopes of $250M Gilead deal
|
| Fri, 16 Oct 2020 02:37:36: | Chutes & Ladders—Biogen veteran Ong joins Flagship Pioneering as CEO-partner
|
